These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37711012)

  • 1. Comparison of Ussing Chamber and Caco-2 Model in Evaluation of Intestinal Absorption Mechanism of Compounds from Different BCS Classifications.
    Tian D; Yang Y; Zhang H; Du H; Zhou H; Wang T
    Drug Metab Bioanal Lett; 2023; 16(2):105-112. PubMed ID: 37711012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an Ussing Chamber System Equipped with Rat Intestinal Tissues to Predict Intestinal Absorption and Metabolism in Humans.
    Guan C; Yang Y; Tian D; Jiang Z; Zhang H; Li Y; Yan J; Zhang C; Chen C; Zhang J; Wang J; Wang Y; Du H; Zhou H; Wang T
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):639-652. PubMed ID: 35733077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique.
    Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL
    Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue.
    Haslam IS; O'Reilly DA; Sherlock DJ; Kauser A; Womack C; Coleman T
    Biopharm Drug Dispos; 2011 May; 32(4):210-21. PubMed ID: 21416475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine.
    Kisser B; Mangelsen E; Wingolf C; Partecke LI; Heidecke CD; Tannergren C; Oswald S; Keiser M
    Curr Protoc Pharmacol; 2017 Jun; 77():7.17.1-7.17.19. PubMed ID: 28640954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum.
    Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H
    Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
    Li H; Jin HE; Shim WS; Shim CK
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption.
    Boisset M; Botham RP; Haegele KD; Lenfant B; Pachot JI
    Eur J Pharm Sci; 2000 May; 10(3):215-24. PubMed ID: 10767599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
    Zhang SY; Ong WSY; Subelzu N; Gleeson JP
    Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.
    Heinen C; Reuss S; Saaler-Reinhardt S; Langguth P
    Eur J Pharm Biopharm; 2013 Sep; 85(1):26-33. PubMed ID: 23958316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs.
    Sjögren E; Eriksson J; Vedin C; Breitholtz K; Hilgendorf C
    Int J Pharm; 2016 May; 505(1-2):361-8. PubMed ID: 27073083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Bioavailability of the Isoflavones Formononetin and Ononin and Their in Vitro Absorption in Ussing Chamber and Caco-2 Cell Models.
    Luo LY; Fan MX; Zhao HY; Li MX; Wu X; Gao WY
    J Agric Food Chem; 2018 Mar; 66(11):2917-2924. PubMed ID: 29504397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantages of the Ussing chamber in drug absorption studies.
    Gotoh Y; Kamada N; Momose D
    J Biomol Screen; 2005 Aug; 10(5):517-23. PubMed ID: 16093561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for absorption screening in drug discovery and development.
    Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
    Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs.
    Forner K; Roos C; Dahlgren D; Kesisoglou F; Konerding MA; Mazur J; Lennernäs H; Langguth P
    Drug Dev Ind Pharm; 2017 Feb; 43(2):338-346. PubMed ID: 27762631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Intestinal Permeability in Rats: A Comparison of Methods.
    Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
    Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers.
    Menon RM; Barr WH
    Biopharm Drug Dispos; 2003 Oct; 24(7):299-308. PubMed ID: 14520683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide transport in rat and human intestine ussing chamber models.
    Wu-Pong S; Livesay V; Dvorchik B; Barr WH
    Biopharm Drug Dispos; 1999 Dec; 20(9):411-6. PubMed ID: 10951429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the absorption of the extracts of Coreopsis tinctoria Nutt. in the intestinal canal in rats using an Ussing chamber.
    Wang J; Aierken G; Li X; Li L; Mao X
    J Ethnopharmacol; 2016 Jun; 186():73-83. PubMed ID: 27045866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.